US Patent Issued to Duke University on Sept. 30 for "CRISPR/Cas9-based repressors for silencing gene targets in vivo and methods of use" (North Carolina Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,631, issued on Sept. 30, was assigned to Duke University (Durham, N.C.).

"CRISPR/Cas9-based repressors for silencing gene targets in vivo and methods of use" was invented by Charles A. Gersbach (Chapel Hill, N.C.) and Pratiksha I. Thakore (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use."

The patent was filed on Jan. 5, 2024, under Application No. 18/405,995.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPT...